ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
17,027.60
0.99%
다우존스 지수
37,903.29
0.00%
Bitcoin
58,243.31
0.01%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) 뉴스

TBPH Theravance Biopharma Inc

8.84
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Theravance Biopharma Inc TBPH 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 8.84 20:00:00
개장가 저가 고가 종가 전일 종가
8.84
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202419:00PRNUSTheravance Biopharma to Report First Quarter 2024 Financial..
10/04/202419:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
27/02/202406:16EDGAR2Form 8-K - Current report
27/02/202406:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
23/02/202410:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202410:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202410:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202410:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202420:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
17/02/202410:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/02/202406:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202420:00PRNUSTheravance Biopharma to Report Fourth Quarter and Full Year..
16/01/202420:16EDGAR2Form 8-K - Current report
05/01/202420:07EDGAR2Form 8-K - Current report
05/01/202420:00PRNUSTheravance Biopharma Announces Results from the Phase 4..
28/12/202320:01EDGAR2Form 8-K - Current report
27/12/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202308:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202307:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202307:06EDGAR2Form 8-K - Current report
22/12/202307:00PRNUSTheravance Biopharma, Inc. Announces Appointment of Jeremy..
18/12/202320:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
23/11/202308:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202320:00PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
15/11/202320:00PRNUSTheravance Biopharma to Participate in the 6th Annual..
13/11/202322:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
10/11/202306:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:53EDGAR2Form 8-K - Current report
08/11/202306:28PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2023..
02/11/202307:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202306:15EDGAR2Form 8-K - Current report
19/10/202319:00PRNUSTheravance Biopharma to Report Third Quarter 2023 Financial..
19/10/202307:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202305:13EDGAR2Form 144 - Report of proposed sale of securities
19/09/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:24EDGAR2Form 144 - Report of proposed sale of securities
12/09/202319:05EDGAR2Form 8-K - Current report
29/08/202319:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
28/08/202319:05PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
25/08/202307:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202307:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202307:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/08/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
TBPH
Theravance Biopharma
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유